Halliburton Company (HAL)
Mexican Exchange · Mexico · prices in MXN · close of 23 Oct 2026
Key indicators
| Last close | MXN 654.00 |
|---|---|
| 52-week range | 473.99 – 750.00 |
| Return, 1 month / 3 months | +12.2% / +12.8% |
| Return, 1 year / 3 years | +36.3% / −17.2% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 40.4% |
| Worst drawdown (1 year) | -27.1% |
| Average daily value traded | 0.12M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Halliburton Company is an oilfield services company based in Houston, Texas. It supplies equipment and services used to drill, complete and produce oil and gas wells, including cementing, stimulation, drilling fluids and completion tools. Its customers are energy companies operating in many countries, and it also provides consulting and project management for field development. The company serves both onshore and offshore markets through a broad range of technical services and products.
Halliburton Company trades under the code HAL on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Halliburton Company (HAL) trades on the Mexican Exchange in Mexico. It last closed at MXN 654.00 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 268 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.3% and over the last three months it rose 12.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 5.1% | ||
| From 52-week high | -12.8% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.8% | ||
| 6-month return | -5.8% | ||
| 12-month return, skipping the last month | 21.4% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.1% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.12M MXN | ||
| Zero-volume days | 65.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.4% |
|---|---|
| 1 month | +12.2% |
| 3 months | +12.8% |
| 6 months | −5.8% |
| 1 year | +36.3% |
| 3 years | −17.2% |
| 5 years | +26.7% |
Signals
| 50-day / 200-day average | 600.73 / 622.04 |
|---|---|
| Golden / death cross (60 days) | Death, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Dec 2019 | MXN 0.1800 |
| 3 Sep 2019 | MXN 0.1800 |
| 4 Jun 2019 | MXN 0.1800 |
| 5 Mar 2019 | MXN 0.1800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.